Average Co-Inventor Count = 2.10
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Mesoblast, Inc (9 from 30 patents)
2. Paradigm Biopharmaceuticals Ltd (5 from 6 patents)
14 patents:
1. 12433913 - Treatment of acute respiratory disease syndrome (ARDS) with polysulfated polysaccharides
2. 12263187 - Treatment of bone marrow pathologies with polysulfated polysaccharides
3. 11752169 - Treatment of pain with polysulfated polysaccharides
4. 11701382 - Treatment of post-operative joint pain with polysulfated polysaccharides
5. 11617763 - Treatment of bone marrow pathologies with polysufated polysaccharides
6. 11135249 - Methods for increasing osteoblastic function
7. 10688134 - Methods of treating or preventing respiratory conditions
8. 10159696 - Methods for treating obesity and/or metabolic syndrome
9. 10028979 - Methods of treating or preventing respiratory conditions
10. 9968640 - Method for treating or preventing a pancreatic dysfunction
11. 9642878 - Methods for increasing osteoblastic function
12. 9480713 - Method for treating diabetic renal failure or syndrome X
13. 9388385 - Methods for treating obesity and/or metabolic syndrome
14. 8894972 - Method for treating or preventing a pancreatic dysfunction